Metformin Exposure in Pregnancy and Childhood Developmental Outcomes
Hannah Gordon, Richard J. Hiscock, Sarah Price, Alexis Shub, Alexandra Roddy Mitchell, Jessica Atkinson, Susan Walker, Anna Forsythe, Stephen Tong, Anthea Lindquist, Roxanne Hastie · 2026
Read Metformin Exposure in Pregnancy and Childhood Developmental Outcomes by Hannah Gordon, Richard J. Hiscock, Sarah Price, Alexis Shub, Alexandra Roddy Mitchell, Jessica Atkinson, Susan Walker, Anna Forsythe, Stephen Tong, Anthea Lindquist, Roxanne Hastie (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628313.txt.
Description
Hannah Gordon and a large team check whether a diabetes drug taken in pregnancy is tied to slower child development at school entry, in work dated 2026. Metformin is prescribed more and more often in pregnancy. In animals it shapes early brain growth, but whether that matters in children was unknown.
Birth records from 2009 to 2020 were linked to a national census of child development taken in the first school year, at ages four to six. Exposure meant a metformin prescription filled during pregnancy. Children were rated for vulnerability across development domains. The huge linked cohort lets small risks show, or lets families be reassured by their absence.
Catalog record
| CREATOR | Hannah Gordon, Richard J. Hiscock, Sarah Price, Alexis Shub, Alexandra Roddy Mitchell, Jessica Atkinson, Susan Walker, Anna Forsythe, Stephen Tong, Anthea Lindquist, Roxanne Hastie |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |